A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Ocular Safety of SCH 530348 in Subjects Participating in the Schering-Plough P04737 Study (TRASM-Secondary Prevention Ocular Safety Study).

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Ocular Safety of SCH 530348 in Subjects Participating in the Schering-Plough P04737 Study (TRASM-Secondary Prevention Ocular Safety Study).

Completed
Phase of Trial: Phase III

Latest Information Update: 07 May 2017

At a glance

  • Drugs Vorapaxar (Primary)
  • Indications Atherosclerosis; Thrombosis
  • Focus Adverse reactions
  • Acronyms TRA-SM
  • Sponsors Merck Sharp & Dohme
  • Most Recent Events

    • 18 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 25 Dec 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 04 Nov 2009 Additional trial locations (Hungary, Israel, Sweden) identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top